about
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well...
Read More
5.99
0.19
(3.28%)
2.2M
XNAS Volume
XNAS 07 Apr, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for Annexon Inc is scheduled for today, for the purpose of Annexon Inc Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
Annexon Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..